Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells

Bone Marrow Transplantation

Volumn 26, Issue 12, 2000, Pages 1325-1331

  Rondelli, D ^a   Re, F ^a   Bandini, G ^a   Raspadori, D ^b   Arpinati, M ^a   Senese, B ^a   Stanzani, M ^a   Bonifazi, F ^a   Falcioni, S ^a   Chirumbolo, G ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Acute myeloid leukemia; Allogeneic PBSC transplant; Chronic myeloid leukemia; GVHD; Lymphocyte reconstitution; Multiple myeloma

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; ANTHRACYCLINE; BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGRAFT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; INFUSION; KINETICS; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; MORTALITY; MULTIPLE MYELOMA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; SIBLING; T LYMPHOCYTE; TIME; TISSUE REGENERATION; WHOLE BODY RADIATION;

ACUTE DISEASE; ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRANSPLANTATION, HOMOLOGOUS;

EID: 17744371629     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702709     Document Type: Article

References (32)

1. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma - Potential advantage of blood over marrow allografts
2. Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony-stimulating factor
3. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)
4. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow
5. Immune reconstitution after blood cell transplantation
6. Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome
7. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from European group for blood and marrow transplantation
8. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
9. Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma
10. Progress in allogeneic hematopoietic stem-cell transplantation for multiple myeloma
11. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: A retrospective comparison of short-term outcome with bone marrow transplantation
12. Big Bu/Cy is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase
13. Consensus conference on acute GVHD grading
14. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients
15. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow
16. + selected PBPC grafts, unselected PBPC or BM grafts
17. + selected grafts with recipients of unmanipulated grafts
18. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies
19. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution
20. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation
21. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation
22. Graft-versus-myeloma
23. Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: A case report
24. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF mobilized peripheral blood cells
25. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo
26. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells
27. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-γ
28. G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function
29. G-CSF mobilizes T helper 2-inducing dendritic cells
30. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells
31. + cells and donor dendritic cell progenitors (DCPs)
32. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient